286463-65-8

Basic information

• Product Name: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)amino)-3-oxopropyl acetate
• Synonyms: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)amino)-3-oxopropyl acetate
• CAS NO: 286463-65-8
• Molecular Weight: 666.728
• Mol File: 286463-65-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)amino)-3-oxopropyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)amino)-3-oxopropyl acetate(286463-65-8)
• EPA Substance Registry System: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)amino)-3-oxopropyl acetate(286463-65-8)

Safety Data

• Hazardous Substances Data: 286463-65-8(Hazardous Substances Data)

Upstream product

• 31680-08-7 4-methoxy-3-nitrobenzaldehyde 
• 21852-50-6 3,4,5-trimethoxybenzyl bromide 
• 3840-31-1 (3,4,5-trimethoxyphenyl)methanol 
• 61240-20-8 triphenyl-(3,4,5-trimethoxybenzyl)phosphonium bromide 
• 313673-23-3 (4-methoxy-3-nitrobenzyl)triphenylphosphonium bromide 
• 162705-13-7 (Z)-1-(4''-methoxy-3''-nitrophenyl)-2-(3',4',5'-trimethoxyphenyl)ethene 
• 61010-34-2 3-nitro-4-methoxybenzyl bromide 
• 119-10-8 4-methoxy-3-nitrotoluene 
• 162705-07-9 3-amino-deoxycombretastatin A₄ 
• 171778-17-9 N^α-(9-fluorenylmethoxycarbonyl)-O-acetyl-L-serine 

Downstream Products

• 253426-24-3 (S,Z)-2-amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide hydrochloride 
• 181816-48-8 (S,Z)-2-amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide 

Relevant articles and documents

Compositions and Methods for Treatment of Cancer

Resistance of randomly dispersed and oxygen-starved lung tumor cells to chemo- and radiotherapy constitutes the vast majority recurrences and death from lung cancer. We use sickle cells derived from humans with sickle cell anemia to target oxygen-deprived

Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs

Several derivatives of combretastatin have been prepared bearing a cyclopropyl unit instead of the natural occurring cis-double bond. Final products and synthetic intermediates were evaluated for their cytotoxic properties in two human cancer cell lines.